D. Avenin

500 total citations
9 papers, 400 citations indexed

About

D. Avenin is a scholar working on Oncology, Surgery and Pharmacology. According to data from OpenAlex, D. Avenin has authored 9 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in D. Avenin's work include Pancreatic and Hepatic Oncology Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). D. Avenin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). D. Avenin collaborates with scholars based in France and United States. D. Avenin's co-authors include Frédèric Selle, Thierry André, L Hannoun, S Houry, S. Provent, Christophe Louvet, Armand de Gramont, Jean‐Pierre Lotz, Christophe Tournigand and Brice Gayet and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Avenin

9 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Avenin France	5	295	291	221	33	32	9	400
Won Ki Kang South Korea	9	431 1.5×	344 1.2×	231 1.0×	27 0.8×	99 3.1×	13	529
Kitao HACHISUKA Japan	9	446 1.5×	187 0.6×	290 1.3×	34 1.0×	59 1.8×	34	520
Chaiyut Charoentum Thailand	7	146 0.5×	144 0.5×	128 0.6×	27 0.8×	14 0.4×	30	244
Friedrich Laengle Austria	10	274 0.9×	214 0.7×	190 0.9×	119 3.6×	27 0.8×	26	407
S. Ohkawa Japan	9	180 0.6×	261 0.9×	166 0.8×	9 0.3×	9 0.3×	20	329
Takayoshi Noguchi Japan	7	149 0.5×	75 0.3×	181 0.8×	31 0.9×	19 0.6×	21	312
Noriyuki Nishino Japan	12	273 0.9×	178 0.6×	115 0.5×	32 1.0×	20 0.6×	32	419
A. Lenauer Austria	9	210 0.7×	355 1.2×	240 1.1×	99 3.0×	28 0.9×	13	444
Joan Llach Spain	9	187 0.6×	184 0.6×	79 0.4×	22 0.7×	36 1.1×	20	306
Sarah M. Cowgill United States	14	386 1.3×	199 0.7×	92 0.4×	24 0.7×	27 0.8×	26	527

Countries citing papers authored by D. Avenin

Since Specialization

Citations

This map shows the geographic impact of D. Avenin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Avenin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Avenin more than expected).

Fields of papers citing papers by D. Avenin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Avenin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Avenin. The network helps show where D. Avenin may publish in the future.

Co-authorship network of co-authors of D. Avenin

This figure shows the co-authorship network connecting the top 25 collaborators of D. Avenin. A scholar is included among the top collaborators of D. Avenin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Avenin. D. Avenin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Selle, Frédèric, Joseph Gligorov, Sandrine Richard, et al.. (2014). Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer. Brazilian Journal of Medical and Biological Research. 48(1). 13–24. 4 indexed citations

Lévy, Pierre, Joseph Gligorov, Martine Antoine, et al.. (2013). Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 139(2). 421–428. 17 indexed citations

Fajac, Anne, Joseph Gligorov, Keyvan Rezaï, et al.. (2010). Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. British Journal of Cancer. 103(4). 560–566. 28 indexed citations

Avenin, D., Joseph Gligorov, Frédèric Selle, et al.. (2005). Analogues de la LHRH : leur utilisation dans le traitement du cancer du sein en situation métastatique et adjuvante☆. Gynécologie Obstétrique & Fertilité. 33(11). 914–919. 2 indexed citations

André, Thierry, Christophe Tournigand, Olivier Rosmorduc, et al.. (2004). Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Annals of Oncology. 15(9). 1339–1343. 309 indexed citations

André, Thierry, F. Maindrault-Gœbel, Laurent Mineur, et al.. (2004). Phase II study of an optimized 5FU-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: A GERCOR study. Journal of Clinical Oncology. 22(14_suppl). 3554–3554. 2 indexed citations

André, Thierry, Christophe Louvet, Pascal Artru, et al.. (2001). A phase II study of gemcitabine and oxaliplatin (gemox) in advanced biliary adenocarcinoma (ABA). Preliminary results. European Journal of Cancer. 37. S19–S19. 8 indexed citations

André, Thierry, et al.. (1998). [Adenocarcinoma of the pancreas. Diagnosis and evaluation].. PubMed. 27(11). 537–8. 2 indexed citations

André, Thierry, Jean Pierre Lotz, Carole Bouleuc, et al.. (1996). Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. Annals of Oncology. 7(2). 173–178. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact